New Zealand vs Portugal: Access to anti-retroviral drugs, female
New Zealand
80.0%
in 2024
Portugal
82.0%
in 2017
New Zealand rank
57th
Portugal rank
56th
Access to anti-retroviral drugs, female over time
- New Zealand
- Portugal
How they compare
Portugal currently reports 82.0% against 80.0% in New Zealand, a difference of 2.0%.
The two have swapped places 1 time across 18 shared years of data; in 2000 it was New Zealand ahead.
New Zealand ranks 57th and Portugal ranks 56th of 141 countries.
Across the 2 decades both report, New Zealand averaged higher in 1 and Portugal in 1.
Head to head by decade
| Decade | New Zealand | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.5% | 36.8% | 10.7% | New Zealand |
| 2010s | 64.0% | 68.2% | 4.2% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, New Zealand or Portugal?
- Portugal, at 82.0% against 80.0% in New Zealand as of 2017.
- What is the difference in access to anti-retroviral drugs, female between New Zealand and Portugal?
- 2.0%, with Portugal ahead.
- How many years of comparable data are there for New Zealand and Portugal?
- 18 years are reported by both, from 2000 to 2017.
- How do New Zealand and Portugal rank globally for access to anti-retroviral drugs, female?
- New Zealand ranks 57th and Portugal ranks 56th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.